Literature DB >> 19452107

Prevalence of depression diagnosis and prescription of antidepressants in East and West Germany: an analysis of health insurance data.

Anke Bramesfeld1, Thomas Grobe, Friedrich Wilhelm Schwartz.   

Abstract

AIM: This study aimed to analyse depression-related factors. The prevalence of depression has been shown in prior surveys to vary between East and West Germany. Do these differences also appear in health insurance data?
METHOD: The outpatient data of a large German statutory health insurance company were analysed for regional differences in (a) the prevalence of depression diagnosis, (b) prescription rates of antidepressants and (c) risk factors of being diagnosed with depression or prescribed antidepressants. Diagnosis rates of depression in outpatient care (ICD-10 diagnosis F32/33) were analysed for the first quarter of 2004, and prescription rates of antidepressants were analysed for the first half of 2004. Odds ratios were calculated for the likelihood of being diagnosed with depression and of being prescribed antidepressants whilst considering socio-demographic and regional variables.
RESULTS: The prevalence of depression diagnosis is up to 41% lower in East Germany than the expected mean rate and 30% above the expected mean rate in Berlin. Regional distribution rates of antidepressant prescriptions largely follow the same pattern as rates for depression diagnosis, with the exception of Berlin where prescription rates are 10% below the expected mean rate. Unemployed persons in West Germany have a higher chance of being diagnosed with depression and of being prescribed antidepressants than those unemployed in East Germany. DISCUSSION: Results correspond greatly to findings of epidemiologic surveys. However, the lower rate of depression diagnosis and prescription rates in East Germany might also be due to fewer mental health professionals practising there and possible differences in reporting style of emotional symptoms. This might contribute to the differences in diagnosis and prescription prevalence but cannot be solely responsible for this phenomenon. Probable causes of the different depression prevalence rates in East and West Germany will be discussed in this analysis. More research into factors impacting on regional differences in the prevalence of depression is needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19452107     DOI: 10.1007/s00127-009-0067-8

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  14 in total

1.  Social representations of major depression in West and East Germany--do differences still persist 11 years after reunification?

Authors:  Michael Beck; Herbert Matschinger; Matthias C Angermeyer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2003-09       Impact factor: 4.328

2.  Test of the 'healthy migrant hypothesis': a longitudinal analysis of health selectivity of internal migration in Indonesia.

Authors:  Yao Lu
Journal:  Soc Sci Med       Date:  2008-07-17       Impact factor: 4.634

3.  Depression in the Chinese: the impact of acculturation.

Authors:  Gordon Parker; Bibiana Chan; Lucy Tully; Maurice Eisenbruch
Journal:  Psychol Med       Date:  2005-10       Impact factor: 7.723

4.  [Affective, somatoform and anxiety disorders in Germany--initial results of an additional federal survey of "psychiatric disorders"].

Authors:  H U Wittchen; N Müller; H Pfister; S Winter; B Schmidtkunz
Journal:  Gesundheitswesen       Date:  1999-12

5.  Patterns of help-seeking behavior for anxiety disorders among the Chinese speaking Australian community.

Authors:  Ka Po Ho; Caroline Hunt; Stephen Li
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-06-23       Impact factor: 4.328

6.  Who is treated, and how, for depression? An analysis of statutory health insurance data in Germany.

Authors:  Anke Bramesfeld; Thomas Grobe; Friedrich Wilhelm Schwartz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-06-27       Impact factor: 4.328

Review 7.  Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review.

Authors:  H U Wittchen
Journal:  J Psychiatr Res       Date:  1994 Jan-Feb       Impact factor: 4.791

8.  The distribution of the common mental disorders: social inequalities in Europe.

Authors:  Tom Fryers; David Melzer; Rachel Jenkins; Traolach Brugha
Journal:  Clin Pract Epidemiol Ment Health       Date:  2005-09-05

9.  Who is diagnosed as suffering from depression in the German statutory health care system? An analysis of health insurance data.

Authors:  Anke Bramesfeld; Thomas G Grobe; Friedrich Wilhelm Schwartz
Journal:  Eur J Epidemiol       Date:  2007-05-05       Impact factor: 12.434

10.  Job Insecurity and the Timing of Parenthood: A Comparison between Eastern and Western Germany: Perceptions de l'instabilité de l'emploi et projet d'enfant: Une comparaison entre Allemagne de l'est et allemagne de l'ouest.

Authors:  Laura Bernardi; Andreas Klärner; Holger von der Lippe
Journal:  Eur J Popul       Date:  2007-11-21
View more
  10 in total

1.  [Provision of outpatient specialist care for mental disorders : Minor regional differences in treatment needs, major regional differences in availability].

Authors:  F Jacobi; M Becker; J Bretschneider; S Müllender; J Thom; U Hapke; W Maier
Journal:  Nervenarzt       Date:  2016-11       Impact factor: 1.214

2.  Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012.

Authors:  Christian J Bachmann; Thomas Lempp; Gerd Glaeske; Falk Hoffmann
Journal:  Dtsch Arztebl Int       Date:  2014-01-17       Impact factor: 5.594

3.  Who receives depression-specific treatment? A secondary data-based analysis of outpatient care received by over 780,000 statutory health-insured individuals diagnosed with depression.

Authors:  Stefanie Boenisch; Rueya-Daniela Kocalevent; Herbert Matschinger; Roland Mergl; Claudia Wimmer-Brunauer; Martin Tauscher; Dietmar Kramer; Ulrich Hegerl; Anke Bramesfeld
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-02-25       Impact factor: 4.328

4.  Longterm persistence and nonrecurrence of depression treatment in Germany: a four-year retrospective follow-up using linked claims data.

Authors:  Christoph J Wagner; Charalabos Markos Dintsios; Florian G Metzger; Helmut L'Hoest; Ursula Marschall; Bjoern Stollenwerk; Stephanie Stock
Journal:  Int J Methods Psychiatr Res       Date:  2018-02-15       Impact factor: 4.035

5.  US regional differences in death rates from depression.

Authors:  Anthony P Polednak
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-04-19       Impact factor: 4.328

6.  New antidepressant utilization pre- and post-bereavement: a population-based study of partners and adult children.

Authors:  Katherine A Ornstein; Melissa Aldridge; Christina Gillezeau; Marie S Kristensen; Tatjana Gazibara; Mogens Groenvold; Lau C Thygesen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-03-17       Impact factor: 4.328

Review 7.  Psychiatry in former socialist countries: implications for north korean psychiatry.

Authors:  Young Su Park; Sang Min Park; Jin Yong Jun; Seog Ju Kim
Journal:  Psychiatry Investig       Date:  2014-10-20       Impact factor: 2.505

8.  Antidepressant prescription practice and related factors in Switzerland: a cross-sectional analysis of health claims data.

Authors:  Elisa Haller; Birgit Watzke; Eva Blozik; Thomas Rosemann; Oliver Reich; Carola A Huber; Markus Wolf
Journal:  BMC Psychiatry       Date:  2019-06-24       Impact factor: 3.630

9.  30 years after the fall of the Berlin Wall: Regional health differences in Germany.

Authors:  Thomas Lampert; Stephan Müters; Benjamin Kuntz; Stefan Dahm; Enno Nowossadeck
Journal:  J Health Monit       Date:  2019-11-01

10.  Depression, Comorbidities, and Prescriptions of Antidepressants in a German Network of GPs and Specialists with Subspecialisation in Anthroposophic Medicine: A Longitudinal Observational Study.

Authors:  Elke Jeschke; Thomas Ostermann; Horst C Vollmar; Manuela Tabali; Harald Matthes
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-06       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.